Making the ordinary, extraordinary: Next generation T cell receptors for precision immunotherapies
57:12
Volition webinar: Nu.Q NETs data insights
54:00
Cancer Immunotherapy in 2024: Progress Towards Curing the Incurable
42:58
QA x Immudex - WEBINAR: Evaluation of TCR-pMHC Affinity and its Implications for T Cell Therapies
47:31
Industry Update: Solid Biosciences
13:16
Trump’s tariff chaos explained | Yanis Varoufakis
33:37
Something Strange Happens When You Trust Quantum Mechanics
32:17
George Friedman: Trump, Putin and Changing Global Realities
18:27